遺伝子解析の世界市場

遺伝子解析の世界市場は2030年までに165億米ドルに達する

2024年に116億米ドルと推定される遺伝子解析の世界市場は、分析期間2024-2030年にCAGR 6.1%で成長し、2030年には165億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである試薬＆キットは、CAGR 6.6％を記録し、分析期間終了までに94億米ドルに達すると予測されます。機器セグメントの成長率は、分析期間中CAGR 4.7%と推定されます。

米国市場は推定32億米ドル、中国はCAGR9.6％で成長予測

米国の遺伝子解析市場は、2024年に32億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに34億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.9%と6.0%と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界の遺伝子解析市場- 主要動向と促進要因のまとめ

遺伝子解析がヘルスケアと科学研究に革命をもたらす理由とは？

遺伝子解析は、DNA配列、遺伝子変異、疾患素因に関する重要な洞察を提供することで、ヘルスケア、農業、生物医学調査に変革をもたらしました。次世代シークエンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、マイクロアレイ技術の進歩により、研究者はかつてない正確さとスピードで遺伝情報を解読することができるようになりました。これらの技術により、遺伝性疾患の特定、がんの早期発見、個別化医療へのアプローチが可能となり、患者ケアと疾病管理に革命をもたらしています。

ヘルスケアにとどまらず、遺伝子解析は法医学、進化生物学、農業においても重要な役割を果たしています。法医学捜査ではDNAプロファイリングが犯罪解決能力を高め、農業では遺伝子解析が高収量で病気に強い作物の育種を促進しています。また、D2C遺伝子検査が利用しやすくなったことで、先祖や健康リスク、遺伝形質に関する洞察を得ることができるようになり、市場成長の原動力となっています。遺伝子解析の用途が拡大し続ける中、ハイスループットシーケンスおよびバイオインフォマティクスソリューションに対する需要は、複数の業界で高まっています。

遺伝子解析の需要を牽引している産業は？

ヘルスケア部門は遺伝子解析テクノロジーの最大の消費者であり、病気のリスク評価、精密医療、生殖医療スクリーニングにゲノムの洞察を活用しています。腫瘍学は主要な重点分野であり、遺伝子検査によって患者固有の遺伝子プロファイルに基づいた標的がん治療が導かれます。さらに、希少疾患の遺伝子スクリーニング、出生前検査、薬理ゲノミクスは、早期診断と治療計画を大幅に改善しました。

農業分野では、遺伝子解析が作物の改良や家畜の育種において極めて重要な役割を果たしています。収量、耐病性、環境適応性に関連する遺伝子を同定することにより、研究者は遺伝子的に最適化された作物を開発し、世界の食糧安全保障の課題に取り組んでいます。バイオテクノロジーや製薬業界もまた、創薬、遺伝子治療研究、マイクロバイオーム解析のために遺伝子解析を利用しています。シーケンサー技術やAIを駆使したバイオインフォマティクスの継続的な進歩により、遺伝子解析は研究や商業アプリケーションに不可欠な存在になりつつあります。

遺伝子解析の最新の技術革新とは？

遺伝子解析の技術革新により、シーケンス精度、データ処理速度、費用対効果が大幅に向上しました。シングルセルシーケンスの開発により、科学者は遺伝子変異を細胞レベルで解析できるようになり、がん診断や神経科学研究が向上しました。さらに、バイオインフォマティクスにおけるAIと機械学習の統合により、ゲノムアノテーション、バリアント解釈、疾患リスク予測が加速しています。

PacBioやOxford Nanoporeなどのロングリードシーケンス技術は、複雑なゲノム構造に対するより包括的な洞察を提供することで、遺伝子解析の能力をさらに拡大した。CRISPRベースの遺伝子編集や合成生物学の進歩も遺伝子解析を補完し、研究者がDNA配列を高精度で改変することを可能にしています。遺伝子研究が進化し続ける中、これらのイノベーションが次世代の診断、治療、農業のブレークスルーを促進すると期待されています。

遺伝子解析市場の成長を促進している要因は？

遺伝子解析市場の成長は、精密医療に対する需要の増加、NGS技術の採用率の上昇、農業やバイオテクノロジーにおけるアプリケーションの拡大など、いくつかの要因によってもたらされています。DNAシーケンシングのコストが低下したことで、遺伝子解析がより身近になり、大規模な集団ゲノミクスプロジェクトや個別化ヘルスケアへの取り組みが可能になりました。さらに、ゲノム研究に対する政府の資金援助や民間の投資により、技術の進歩や商業的な導入が加速しています。

遺伝性疾患とがんの有病率の増加は、遺伝子スクリーニングと早期診断の必要性をさらに高めています。消費者が自分の健康状態、家系、生活習慣の素因についての洞察を求めているため、消費者直接遺伝子検査市場も拡大しています。さらに、遺伝子データ解析におけるクラウドコンピューティングとAIの統合により、効率性と拡張性が向上し、市場拡大を後押ししています。遺伝子解析が複数の業界で不可欠なツールとなるにつれ、その採用は拡大し続け、ゲノミクス主導のイノベーションと個別化医療の未来を形作るものと予想されます。

セグメント

製品（試薬・キット、機器、ソフトウェア）、検査（遺伝学的予測、キャリア、出生前・新生児、疾患診断、ファーマコゲノム、その他）、技術（次世代シーケンス技術、リアルタイムPCRシステム技術、その他の技術）、用途（がん、遺伝子疾患、循環器疾患、希少疾患、感染症、その他）、最終用途（病院、研究開発研究所、診断センター、その他）

調査対象企業の例

• Autumn DNA
• Blueprint Genetics
• Caris Life Sciences
• Color Health, Inc.
• Coriell Life Sciences
• deCODE genetics
• Exact Sciences Corporation
• Foundation Medicine
• Fulgent Genetics
• Gene by Gene
• Genomic Life
• Guardant Health
• Illumina, Inc.
• Invitae Corporation
• Myriad Genetics
• NeoGenomics Laboratories
• Newtopia Inc.
• Qiagen N.V.
• Sophia Genetics
• Thermo Fisher Scientific

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Genetic Analysis Market to Reach US$16.5 Billion by 2030

The global market for Genetic Analysis estimated at US$11.6 Billion in the year 2024, is expected to reach US$16.5 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 9.6% CAGR

The Genetic Analysis market in the U.S. is estimated at US$3.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Genetic Analysis Market - Key Trends & Drivers Summarized

Why Is Genetic Analysis Revolutionizing Healthcare and Scientific Research?

Genetic analysis has transformed healthcare, agriculture, and biomedical research by providing critical insights into DNA sequences, genetic variations, and disease predisposition. Advances in next-generation sequencing (NGS), polymerase chain reaction (PCR), and microarray technologies have enabled researchers to decode genetic information with unprecedented accuracy and speed. These techniques allow for the identification of hereditary diseases, early cancer detection, and personalized medicine approaches, revolutionizing patient care and disease management.

Beyond healthcare, genetic analysis plays a crucial role in forensic science, evolutionary biology, and agriculture. In forensic investigations, DNA profiling has enhanced crime-solving capabilities, while in agriculture, genetic analysis has facilitated the breeding of high-yield, disease-resistant crops. The increasing accessibility of direct-to-consumer (DTC) genetic testing has also driven market growth, allowing individuals to gain insights into their ancestry, health risks, and inherited traits. As the applications of genetic analysis continue to expand, the demand for high-throughput sequencing and bioinformatics solutions is rising across multiple industries.

Which Industries Are Driving the Demand for Genetic Analysis?

The healthcare sector is the largest consumer of genetic analysis technologies, leveraging genomic insights for disease risk assessment, precision medicine, and reproductive health screening. Oncology has been a primary focus area, with genetic tests guiding targeted cancer therapies based on a patient’s unique genetic profile. Additionally, genetic screening for rare diseases, prenatal testing, and pharmacogenomics has significantly improved early diagnosis and treatment planning.

In agriculture, genetic analysis is playing a pivotal role in crop improvement and livestock breeding. By identifying genes associated with yield, disease resistance, and environmental adaptability, researchers are developing genetically optimized crops to address global food security challenges. The biotechnology and pharmaceutical industries also rely on genetic analysis for drug discovery, gene therapy research, and microbiome analysis. With continuous advancements in sequencing technologies and AI-driven bioinformatics, genetic analysis is becoming an integral part of research and commercial applications.

What Are the Latest Technological Innovations in Genetic Analysis?

Technological innovations in genetic analysis have significantly enhanced sequencing accuracy, data processing speed, and cost-effectiveness. The development of single-cell sequencing has enabled scientists to analyze genetic variations at the cellular level, improving cancer diagnostics and neuroscience research. Additionally, the integration of AI and machine learning in bioinformatics has accelerated genome annotation, variant interpretation, and disease risk prediction.

Long-read sequencing technologies, such as PacBio and Oxford Nanopore, have further expanded the capabilities of genetic analysis by providing more comprehensive insights into complex genomic structures. Advances in CRISPR-based gene editing and synthetic biology are also complementing genetic analysis, allowing researchers to modify DNA sequences with high precision. As genetic research continues to evolve, these innovations are expected to drive the next generation of diagnostic, therapeutic, and agricultural breakthroughs.

What Factors Are Fueling the Growth of the Genetic Analysis Market?

The growth in the genetic analysis market is driven by several factors, including increasing demand for precision medicine, rising adoption of NGS technologies, and expanding applications in agriculture and biotechnology. The declining cost of DNA sequencing has made genetic analysis more accessible, enabling large-scale population genomics projects and personalized healthcare initiatives. Additionally, government funding and private investments in genomic research have accelerated technological advancements and commercial adoption.

The growing prevalence of genetic disorders and cancer has further increased the need for genetic screening and early diagnostics. The direct-to-consumer genetic testing market is also expanding, as consumers seek insights into their health, ancestry, and lifestyle predispositions. Moreover, the integration of cloud computing and AI in genetic data analysis has improved efficiency and scalability, driving market expansion. As genetic analysis becomes an essential tool across multiple industries, its adoption is expected to continue growing, shaping the future of genomics-driven innovation and personalized medicine.

SCOPE OF STUDY:

The report analyzes the Genetic Analysis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Kits, Instruments, Software); Test (Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Other Tests); Technology (Next-Generation Sequencing Technology, Real-Time PCR System Technology, Other Technologies); Application (Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application, Other Applications); End-Use (Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Autumn DNA
• Blueprint Genetics
• Caris Life Sciences
• Color Health, Inc.
• Coriell Life Sciences
• deCODE genetics
• Exact Sciences Corporation
• Foundation Medicine
• Fulgent Genetics
• Gene by Gene
• Genomic Life
• Guardant Health
• Illumina, Inc.
• Invitae Corporation
• Myriad Genetics
• NeoGenomics Laboratories
• Newtopia Inc.
• Qiagen N.V.
• Sophia Genetics
• Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Genetic Analysis - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Explosion of Genomic Data and Falling Sequencing Costs Drive Rapid Expansion of Genetic Analysis Applications
  • Increased Adoption of Genetic Testing for Personalized Medicine Fuels Growth in Diagnostic and Predictive Genomics
  • Expansion of Population-Scale Genomics Programs Spurs Demand for High-Throughput Genetic Analysis Platforms
  • Wider Use of NGS, qPCR, and Microarrays Across Research and Clinical Applications Broadens Technology Adoption
  • Rising Investment in Precision Oncology and Companion Diagnostics Accelerates Genetic Biomarker Discovery
  • OEM Integration of AI and Bioinformatics in Genetic Analysis Enhances Interpretation Accuracy and Clinical Relevance
  • Demand for Preimplantation and Prenatal Genetic Testing Grows in Line with Advancements in Reproductive Health
  • Growth in Consumer Genomics and Direct-to-Consumer Testing Platforms Spurs Market Awareness and Uptake
  • Expansion of Pharmacogenomics in Drug Development Supports Broader Adoption in Clinical Trials
  • Integration of Epigenetic and Transcriptomic Analysis Expands Multi-Omics Research Scope
  • OEM Partnerships with Biopharma Companies Strengthen Validation of Genetic Biomarkers for Drug Targeting
  • Rising Role of Genetic Analysis in Rare Disease Diagnosis Enhances Access to Precision Healthcare Solutions
  • Healthcare Payer Support and Reimbursement for Genetic Tests Drives Broader Adoption in Clinical Settings
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Genetic Analysis Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Genetic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Next-Generation Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Next-Generation Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Next-Generation Sequencing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Real-Time PCR System Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Real-Time PCR System Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Real-Time PCR System Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Genetic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Genetic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Genetic Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cardiovascular Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Rare Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Rare Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Rare Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Research & Development Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Research & Development Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Research & Development Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Predictive Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Predictive Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Predictive Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Carrier Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Carrier Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Carrier Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Prenatal & Newborn Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Prenatal & Newborn Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Prenatal & Newborn Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Disease Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Disease Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: World 15-Year Perspective for Disease Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 65: World Recent Past, Current & Future Analysis for Pharmacogenomic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: World Historic Review for Pharmacogenomic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: World 15-Year Perspective for Pharmacogenomic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 68: World Recent Past, Current & Future Analysis for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: World Historic Review for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: World 15-Year Perspective for Other Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 71: USA Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 74: USA Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: USA Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: USA 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 77: USA Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: USA Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: USA 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 80: USA Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: USA Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: USA 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 83: USA Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: USA Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: USA 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Canada 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 89: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Canada Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Canada 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 92: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Canada Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Canada 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 95: Canada Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Canada Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Canada 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 98: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Canada Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Canada 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• JAPAN
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 101: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Japan Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Japan 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 104: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Japan Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Japan 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 107: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Japan Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Japan 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 110: Japan Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Japan Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Japan 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 113: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Japan Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Japan 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• CHINA
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 116: China Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: China Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: China 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 119: China Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: China Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: China 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 122: China Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: China Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: China 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 125: China Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: China Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: China 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 128: China Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: China Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: China 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• EUROPE
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 131: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 132: Europe Historic Review for Genetic Analysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Europe 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 134: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Europe Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Europe 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 137: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Europe Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Europe 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 140: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Europe Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Europe 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 143: Europe Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Europe Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Europe 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 146: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Europe Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Europe 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• FRANCE
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 149: France Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: France Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: France 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 152: France Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: France Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: France 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 155: France Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: France Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: France 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 158: France Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: France Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: France 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 161: France Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: France Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: France 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• GERMANY
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 164: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Germany Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Germany 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 167: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Germany Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Germany 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 170: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Germany Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Germany 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 173: Germany Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Germany Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Germany 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 176: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Germany Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Germany 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 179: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Italy Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Italy 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 182: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Italy Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Italy 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 185: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Italy Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Italy 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 188: Italy Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Italy Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Italy 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 191: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Italy Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Italy 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 194: UK Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UK Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: UK 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 197: UK Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: UK Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: UK 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 200: UK Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: UK Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: UK 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 203: UK Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: UK Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: UK 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 206: UK Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: UK Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: UK 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 209: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Spain Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Spain 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 212: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Spain Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Spain 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 215: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Spain Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Spain 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 218: Spain Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Spain Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Spain 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 221: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Spain Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Spain 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 224: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Russia Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Russia 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 227: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Russia Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Russia 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 230: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Russia Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Russia 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 233: Russia Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Russia Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Russia 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 236: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Russia Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Russia 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Europe Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Europe 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Europe Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Europe 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Europe Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Europe 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Europe Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Europe 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Europe Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Europe 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Asia-Pacific Historic Review for Genetic Analysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Asia-Pacific 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Asia-Pacific Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Asia-Pacific 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 260: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Asia-Pacific Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Asia-Pacific 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 263: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Asia-Pacific Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Asia-Pacific 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 266: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Asia-Pacific Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Asia-Pacific 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 269: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Asia-Pacific Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Asia-Pacific 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 272: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Australia Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Australia 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 275: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Australia Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Australia 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 278: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Australia Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Australia 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 281: Australia Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Australia Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Australia 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 284: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Australia Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Australia 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• INDIA
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 287: India Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: India Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: India 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 290: India Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: India Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: India 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 293: India Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: India Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: India 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 296: India Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: India Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: India 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 299: India Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: India Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: India 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 302: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: South Korea Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: South Korea 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 305: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: South Korea Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: South Korea 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 308: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: South Korea Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: South Korea 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 311: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: South Korea Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: South Korea 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 314: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: South Korea Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: South Korea 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Asia-Pacific Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 320: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Asia-Pacific Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 323: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Asia-Pacific Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 326: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Asia-Pacific Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 329: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Asia-Pacific Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 332: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 333: Latin America Historic Review for Genetic Analysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Latin America 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 335: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Latin America Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Latin America 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 338: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Latin America Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Latin America 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 341: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Latin America Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Latin America 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 344: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Latin America Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Latin America 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 347: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Latin America Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Latin America 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 350: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Argentina Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Argentina 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 353: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Argentina Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Argentina 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 356: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Argentina Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Argentina 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 359: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Argentina Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Argentina 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 362: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Argentina Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Argentina 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 365: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Brazil Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Brazil 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 368: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Brazil Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Brazil 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 371: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Brazil Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Brazil 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 374: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Brazil Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Brazil 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 377: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Brazil Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Brazil 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 380: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Mexico Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Mexico 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 383: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Mexico Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Mexico 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 386: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Mexico Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Mexico 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 389: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Mexico Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Mexico 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 392: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Mexico Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Mexico 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Latin America Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Rest of Latin America 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 398: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Latin America Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Rest of Latin America 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 401: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Latin America Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Rest of Latin America 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 404: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Latin America Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Rest of Latin America 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 407: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Latin America Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Rest of Latin America 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 410: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 411: Middle East Historic Review for Genetic Analysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Middle East 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 413: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Middle East Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Middle East 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 416: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Middle East Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Middle East 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 419: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Middle East Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Middle East 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 422: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Middle East Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 424: Middle East 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 425: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Middle East Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 427: Middle East 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 428: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Iran Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 430: Iran 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 431: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Iran Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 433: Iran 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 434: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Iran Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 436: Iran 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 437: Iran Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Iran Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 439: Iran 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 440: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Iran Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 442: Iran 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 443: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Israel Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 445: Israel 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 446: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 447: Israel Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 448: Israel 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 449: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 450: Israel Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 451: Israel 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 452: Israel Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 453: Israel Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 454: Israel 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 455: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 456: Israel Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 457: Israel 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 459: Saudi Arabia Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 460: Saudi Arabia 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 461: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 462: Saudi Arabia Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 463: Saudi Arabia 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 464: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 465: Saudi Arabia Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 466: Saudi Arabia 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 467: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 468: Saudi Arabia Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 469: Saudi Arabia 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 470: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 471: Saudi Arabia Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 472: Saudi Arabia 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 473: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 474: UAE Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 475: UAE 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 476: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 477: UAE Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 478: UAE 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 479: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 480: UAE Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 481: UAE 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 482: UAE Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 483: UAE Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 484: UAE 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 485: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 486: UAE Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 487: UAE 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 489: Rest of Middle East Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 490: Rest of Middle East 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 491: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 492: Rest of Middle East Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 493: Rest of Middle East 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 494: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 495: Rest of Middle East Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 496: Rest of Middle East 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 497: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 498: Rest of Middle East Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 499: Rest of Middle East 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 500: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 501: Rest of Middle East Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 502: Rest of Middle East 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• AFRICA
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 503: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 504: Africa Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 505: Africa 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 506: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 507: Africa Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 508: Africa 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 509: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 510: Africa Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 511: Africa 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 512: Africa Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 513: Africa Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 514: Africa 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 515: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 516: Africa Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 517: Africa 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030

IV. COMPETITION